Alnylam Pharmaceuticals reported $2.81B in Current Assets for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Agios Pharmaceuticals AGIO:US $ 1064.23M 241.05M
Arrowhead Research ARWR:US $ 417.63M 79.35M
Avrobio Inc AVRO:US 170.92M 28.22M
IONIS PHARMACEUT IONS:US $ 2345M 189.26M
Mirati Therapeutics MRTX:US $ 1343.12M 164.87M
Regulus Therapeutics RGLS:US $ 57.93M 7.3M
Sangamo Biosciences SGMO:US $ 340.06M 58.7M
Xencor XNCR:US $ 505.97M 81.6M